Mean values (± standard deviation) of hormonal parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of electrolyte concentrations before and after CWI. by Aneta Teległów (9570190)

Subjects:

Related inflammation evaluation indexes before and after operation (mean±standard deviation). by Na Wang (193263)

Subjects:

Baseline data of each group (mean±standard deviation)/n (%)/(M(IQR)). by Na Wang (193263)

Subjects:

Temporal change and intergroup comparison of vessel area mean blur rate following eye drop administration. by Nana Takahashi (9999164)

Subjects:

Temporal change and intergroup comparison of tissue area mean blur rate following eye drop administration. by Nana Takahashi (9999164)

Subjects:

Temporal change in IgE. by Hiromi Yamaguchi (2396248)

Subjects:

Temporal changes in IgE. by Hiromi Yamaguchi (2396248)

Subjects:

Temporal changes in IgG. by Hiromi Yamaguchi (2396248)

Subjects:

Radiological outcomes: Adjusted mean (standard deviation) ^b'*'. by Seungyoon Paik (14659575)

Subjects:

Adjusted mean values from the mixed-effects model for clinical outcomes. by Seungyoon Paik (14659575)

Subjects:

Clinical outcomes: Adjusted mean (standard deviation) ^b'*'. by Seungyoon Paik (14659575)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

Subjects:

Overexpression of miR-195-3p and miR-206 does not significantly decrease Dicer 3’UTR expression in the absence of Mov10. by Monica C. Lannom (11772729)

Depletion of ATRX in fibroblasts decreases the efficiency of viral genome packaging. by Ryan M. Walter (19550606)

“…<b>J)</b> Data from panel I for the percent packaged is calculated by the ratio of resistant DNA to total. <b>K)</b> Fold decrease is calculated as the negative fold change of percent packaged DNA between DMSO and Letermovir treatment. …”

The implementation of the Level III NICU at GPHC was associated with a decrease in the monthly inborn mortality rate as a percent of all live births. by Sara Singh (10774377)

Changes in circulatory variables during CPB. by Vincent Pey (21433304)

Pathway analysis using GRB2, a significantly connected and downregulated protein as the focus. by Eiman Y. Ibrahim (10731078)